Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9996)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 8, 2017 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lovett GC, Nguyen T, Iser DM, Holmes JA, Chen R, Demediuk B, Shaw G, Bell SJ, Desmond PV, Thompson AJ. Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience. World J Hepatol 2017; 9(1): 48-56 [PMID: 28105258 DOI: 10.4254/wjh.v9.i1.48] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i1/48.htm |
| Number | Citing Articles |
| 1 |
Joel S. Emery, Jordan J. Feld. Treatment of hepatitis B virus with combination therapy now and in the future. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 347 doi: 10.1016/j.bpg.2017.04.007
|
| 2 |
Jean Sehonou, Aboudou Raïmi Kpossou, Samuel Guido, Comlan N’dehougbea Martin Sokpon, Koffi Rodolph Vignon, Jacques Vigan. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Patients Treated for Hepatitis B in the National University Hospital of Cotonou. Open Journal of Gastroenterology 2018; 8(06): 213 doi: 10.4236/ojgas.2018.86024
|
| 3 |
Guo-Qing Yin, Jun Li, Bei Zhong, Yong-Fong Yang, Mao-Rong Wang. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage. World Journal of Gastroenterology 2021; 27(8): 666-676 doi: 10.3748/wjg.v27.i8.666
|
| 4 |
Ittipat Meewan, Jiraporn Panmanee, Nopphon Petchyam, Pichaya Lertvilai. HBCVTr: an end-to-end transformer with a deep neural network hybrid model for anti-HBV and HCV activity predictor from SMILES. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59933-4
|
| 5 |
Shahnaz Sali, Maryam Nasiri. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad Hospital. Jundishapur Journal of Natural Pharmaceutical Products 2019; 14(3) doi: 10.5812/jjnpp.63023
|
| 6 |
Abdullah Bahnacy, Mabrouk Ghonaim, Esraa Mamdouh El Hosiny, Abdelnaser Abdelaty Gadallah. Occult Hepatitis (B) Infection in Hepatitis (C) Virus Infection Patients after the Treatment with Direct Acting Antiviral Drugs. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 2529 doi: 10.3889/oamjms.2022.7799
|
| 7 |
José Ángel Cuenca-Gómez, Ana Belén Lozano-Serrano, María Teresa Cabezas-Fernández, Manuel Jesús Soriano-Pérez, José Vázquez-Villegas, Matías Estévez-Escobar, Isabel Cabeza-Barrera, Joaquín Salas-Coronas. Chronic hepatitis B genotype E in African migrants: response to nucleos(t)ide treatment in real clinical practice. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3469-y
|
| 8 |
Long Jianfei, Li Ling, Zhang Yu, Zhang Jiming, Wang Bin. Tooth loss associated with the use of tenofovir disoproxil fumarate. Journal of Clinical Pharmacy and Therapeutics 2020; 45(6): 1478 doi: 10.1111/jcpt.13219
|
| 9 |
Muhammad Sohaib Asghar, Muhammad Nadeem Ahsan, Uzma Rasheed, Maira Hassan, Rumael Jawed, Marium B Abbas, Rabail Yaseen, Syed Anosh Ali Naqvi, Hera Rizvi, Mashaal Syed. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study. Cureus 2020; doi: 10.7759/cureus.12294
|
| 10 |
Bingchen Ouyang, Fang Zhou, Le Zhen, Ying Peng, Jianguo Sun, Qianying Chen, Xiaoliang Jin, Guangji Wang, Jingwei Zhang. Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC–MS/MS method. Journal of Pharmaceutical and Biomedical Analysis 2017; 146: 147 doi: 10.1016/j.jpba.2017.08.028
|
| 11 |
Jie Luo, Xu You, Yutian Chong, Yuankai Wu, Jiao Gong, Yusheng Jie, Xinhua Li, Sujuan Xi, Zhiwei Zhang, Yufeng Zhang, Dongying Xie, Zhanyi Li, Xiangyong Li. Efficacy of long‑term treatment with tenofovir in Chinese nucleos(t)ide‑na�ve chronic hepatitis B patients regardless of baseline viral load. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7547
|
| 12 |
Pietro Lampertico, Thomas Berg, Maria Buti, Anita Pathil, Joerg Petersen, Stephen D. Ryder, Fabien Zoulim, Irina Botros, John F. Flaherty, Belinda Jump, Marjoleine L. Op den Brouw, Anna van Troostenburg, Heribert Ramroth. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study. Alimentary Pharmacology & Therapeutics 2020; 52(3): 500 doi: 10.1111/apt.15901
|
| 13 |
Robert J. Wong, Ramsey C. Cheung. Real-World Safety and Effectiveness of Oral Nucleos(t)ide Analogs in the Treatment of Chronic Hepatitis B Virus Infection. Current Hepatology Reports 2021; 20(4): 144 doi: 10.1007/s11901-021-00571-z
|
| 14 |
Hannah Beck, Nishaanth Dalavaye, Kalaikshiga Kengadaran, Mosammath Monira Khatun, Ria Hitesh Patel, Taif Al-Rubaye, Laith Alrubaiy. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments. Gastrointestinal Disorders 2024; 6(3): 784 doi: 10.3390/gidisord6030054
|
| 15 |
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate. Gut and Liver 2019; 13(1): 93 doi: 10.5009/gnl18183
|
| 16 |
Eun-Hyung Yoo, Hyun-Jung Cho. Clinical response to long-term tenofovir monotherapy in Korean chronic hepatitis B patients. Clinica Chimica Acta 2017; 471: 308 doi: 10.1016/j.cca.2017.06.019
|
| 17 |
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1654620
|
| 18 |
Hong Thai, James Lara, Xiaojun Xu, Kathryn Kitrinos, Anuj Gaggar, Henry Lik Yuen Chan, Guo-liang Xia, Lilia Ganova-Raeva, Yury Khudyakov. Complex genetic encoding of the hepatitis B virus on-drug persistence. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72467-9
|
| 19 |
Jeanne Perino, Christine N. Adams. The Importance of Hepatitis B Antigen Screening in Pregnancy. Neonatal Network 2020; 39(6): 363 doi: 10.1891/0730-0832/11-T-657
|
| 20 |
Qian Zhang, Hong Peng, Xiaoqing Liu, Huimin Wang, Jinjie Du, Xinhua Luo, Hong Ren, Peng Hu. Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00046
|
| 21 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|